Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
V-Clip Pharmaceuticals
San Marino, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
V-Clip Pharmaceuticals developed a mechanism of action for Thymus Nuclear Protein (TNP), a mixture of peptides from thymic histones, designed to bind antigen-presenting cells and redirect immune responses. TNP demonstrated 25%-35% viral load reduction in HIV patients across six international trials and showed potential in other immune diseases like Lyme Disease (animal model). Research was aimed toward IND filing for targeted peptides.
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Peptides
- Industry
- Biotech
02
Partnerships
University of Colorado
Beyond the preview
Go deeper on V-Clip Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on V-Clip Pharmaceuticals.